Moleculin Biotech, Inc. Convertible Notes Payable, Current
Moleculin Biotech, Inc. (MBRX) had Convertible Notes Payable, Current of $0 as of 2017-12-31, per its 10-K filed 2018-03-28.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ConvertibleNotesPayableCurrent · last filed 2018-03-28
- 2017-12-31: Convertible Notes Payable, Current $0.00.
- 2017-09-30: Convertible Notes Payable, Current $0.00.
- 2017-06-30: Convertible Notes Payable, Current $0.00.
- 2017-03-31: Convertible Notes Payable, Current $108.00K.
| Period end | Convertible Notes Payable, Current | Convertible Notes Payable, Current as first filed |
|---|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-03-28 | |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $0.00 10-Q · filed 2017-08-11 | |
| 2017-03-31 | $108.00K 10-Q · filed 2017-05-12 | |
| 2016-12-31 | $296.00K 10-K · filed 2018-03-28 | $296.41K 10-K · filed 2017-04-03 |
| 2016-09-30 | $297.66K 10-Q · filed 2016-11-21 | |
| 2016-06-30 | $431.64K 10-Q · filed 2016-11-21 | |
| 2016-05-31 | $180.00K 10-Q · filed 2017-08-11 | |
| 2016-03-31 | $615.00K 10-Q · filed 2016-06-16 | |
| 2015-12-31 | $450.00K 10-K · filed 2017-04-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |